Affiliation:
1. Volgograd State Medical University
Abstract
The aim is to identify the features of Klotho protein expression in the epithelium of the convoluted tubules of the kidney during prolonged experimental hyperglycemia and pharmacological correction with GABA derivatives. Material and methods. The study used 50 mongrel male rats (initial weight: 330,0–360,0 g) with streptozotocin diabetes lasting 6 months. 6 months after the injection of streptozotocin (60 mg/kg), animals with a glycemic level of ≥ 15 mmol/l were included in the study (after 4 hours of food deprivation), then GABA derivatives (aminalon, mefargine, succicard) were administered orally for 30 days. Proteinuria and serum creatinine concentrations were evaluated. After euthanasia, kidney tissue was fixed in buffered neutral formalin and examined using immunofluorescence microscopy. The intensity of the glow was evaluated based on a visual-analog scale. Results. In the group with chronic hyperglycemia without treatment, there was a significant increase in the protein content in daily urine and serum creatinine levels (p<0,05). In the group of animals with chronic hyperglycemia without treatment, there was a significant decrease in the expression of Klotho protein compared to the group of intact animals during immunofluorescence analysis. In the group treated with the GABA derivative succicard, there was an improvement in the functional state of the kidneys, accompanied by a significant increase (p≤0,0001) in the area of Klotho-positive material in the epithelium of the convoluted tubules of the kidney in relation to the group of animals with prolonged hyperglycemia without treatment. Conclusion. Prolonged hyperglycemia causes severe renal dysfunction in rats with streptozotocin diabetes: an increase the proteinuria and serum creatinine levels is accompanied by a decrease in the expression of Klotho protein in the kidneys. The GABA derivative succicard with course administration improves kidney function and this effect is accompanied by an increase in the expression of Klotho protein.
Reference27 articles.
1. Nesterova A.A., Glinka E.Yu., Tyurenkov I.N., Perfilova V.N. Protein Klotho – Universal Regulator of Physiological Processes in the Organism. Progress in Physiological Science. 2020;51(2):88–104 (In Russ.). doi: 10.31857/S0301179820020083
2. Spasov A.A., Voronkova M.P., Snigur G.L. Metodicheskie rekomendatsii po doklinicheskomu izucheniyu peroral'nykh lekarstvennykh sredstv dlya lecheniya sakharnogo diabeta. Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv: pod red. A.N. Mironova. Ch.1. M.: Grif i K, 2012; 670–84 (In Russ.).
3. Tyurenkov IN, Faibisovich TI, Dubrovina MA, Bakulin DA, Kurkin DV. Gabaergic System in The Regulation of the Functioning of Pancreas BetaCells in Normal Physiological Conditions And In Diabetes. Progress in Physiological Science. 2023;54(2):86–104. doi: 10.31857/s030117982302008x (In Russ.).
4. Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nature Reviews Nephrology. 2018 Apr 13;14(6):361–77. doi: 10.1038/s41581-018-0001-y
5. Buendïa P, Ramı́rezR, Aljama P, Carracedo J. Klotho Prevents Translocation of NFκB. Vitamins and hormones. 2016 Jan 1;(101):119–50. doi: 10.1016/bs.vh.2016.02.005